MPP inks deal with French pharma firm to fight malaria in low-income countries

Malaria remains endemic in 91 countries representing half of the world’s population | Licence is key to allow rapid access to innovation for those who need it most.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Voluntary licensing opens up HIV treatment to 100 countries

6 December 2022 Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees.

Big Pharma

WHO lays bare deaths from counterfeit drugs

30 November 2017 The World Health Organization (WHO) has released a study on the public health impact of counterfeit drugs, showing that tens of thousands of children die as a result of the problem every year.

Americas

Bill Gates venture and GE sign malaria licensing deal with Access Bio

13 July 2017 A collaboration between Bill Gates and Intellectual Ventures , in partnership with conglomerate GE, has signed a licensing deal with US diagnostics technology company Access Bio to make and sell tools for “rapidly” identifying asymptomatic malaria.